CAT and breast cancer: Compared with CK, the catalase activities in the BMF, BC, and CMB treatments significantly increased by 23.19%, 26.60%, and 41.60% at 50 days, respectively, and by 6.68%, 29.07%, and 27.43% at 100 days, respectively.